Table 2.
Comparative analysis of demographic and clinical data of COVID-19 associated rhino–orbital–cerebral mucormycosis case series6-11.
| Study | Cases | Patients with current or past COVID-19 infection | Patients with no history of COVID-19 infection | Diabetes mellitus (DM) | Cerebral involvement | Number of patients received surgical treatment | Death | Remarks |
|---|---|---|---|---|---|---|---|---|
| 1.Fouad et al (2020)6 | 12 | 6 | 6 | 9 | 8 | 7 | 6 | — |
| 2. Buil et al (2020-2021)7 | 4 | 4 | — | 2 | — | 1 | 3 | |
| 3. Nehara et al (2020)8 | 5 | 5 | 5 | 3 | — | 2 | ||
| 4. John et al (2019-2021)9 | 41 | 38 | 3 | 41* | 14 | 33 | 20 | *8 had new onset DM |
| 5. Sharma et al (2020)10 | 23 | 23 | — | 21 | 2 | 23 | — | |
| 6. Moorthy et al (2020)11 | 18 | 18 | 16 | 9 | 18 | 6 | — | |
| 7. Naruka et al (present study) (2021) | 79 | 79 | 79# | 9 | 79 | 14 | #12 had new onset DM | |